Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.70 |
| ▸ | MAG | P20916 | 9/20 | 0.67 |
| ▸ | SELP | P16109 | 2/20 | 0.66 |
| ▸ | SELL | P14151 | 1/20 | 0.66 |
| ▸ | SELE | P16581 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29390469 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL25658073 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL29376404 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL30001490 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL14362211 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL19922285 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL24529621 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL4312517 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL20885234 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL25662685 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4409966-B1 | INDICATING NETWORK SUPPORT OF VARIOUS SIDELINK (SL) FUNCTIONALITY | ERICSSON TELEFON AB L M (SE) | 2025-06-25 | — | — | EP | claimed |
| CN-119678997-A | Breast milk oligosaccharide for regulating and controlling butyric acid and improving intestinal microenvironment health and application thereof | 内蒙古伊利实业集团股份有限公司 | 2025-03-25 | — | — | CN | claimed |
| EP-3277287-B1 | MIXTURES OF HUMAN MILK OLIGOSACCHARIDES COMPRISING 3 '-O-SIALYLLACTOSE | GLYCOM AS (DK) | 2023-11-22 | — | — | EP | claimed |
| EP-4252538-A1 | BREAST MILK OLIGOSACCHARIDE FOR IMPROVING INTESTINAL MICROENVIRONMENT HEALTH AND USE THEREOF | Inner Mongolia Yili Industrial Group Co., Ltd. (CN) | 2023-10-04 | — | — | EP | claimed |
| US-20230285431-A1 | Human Milk Oligosaccharide for Improving Health of Intestinal Microenvironment and Use Thereof | INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD. (CN) | 2023-09-14 | — | — | US | claimed |
| CN-114568504-A | Breast milk oligosaccharide for regulating butyric acid and improving intestinal microenvironment health and application thereof | 内蒙古伊利实业集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114568526-A | Mother emulsified infant formula powder for improving intestinal microenvironment health and application thereof | 内蒙古伊利实业集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114568697-A | Human milk oligosaccharide capable of regulating intestinal macrophages and activating immunity and application thereof | 内蒙古伊利实业集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114568527-A | Mother emulsified infant formula powder for improving intestinal microenvironment health and application thereof | 内蒙古伊利实业集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114568528-A | Infant formula food capable of regulating and controlling intestinal immunity and application thereof | 内蒙古伊利实业集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| WO-2022110542-A1 | BREAST MILK OLIGOSACCHARIDE FOR IMPROVING INTESTINAL MICROENVIRONMENT HEALTH AND USE THEREOF | 内蒙古伊利实业集团股份有限公司 | 2022-06-02 | — | — | WO | claimed |
| CN-114522175-A | Composition for preventing or treating necrotizing enterocolitis in infants and young children | 雀巢产品有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-114468302-A | Composition for preventing or treating URT infections in infants or young children at risk | 雀巢产品有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-114038095-A | Emergency code unlocking method and system | 南京东屋电气有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-120812484-B | Electronic equipment and audio signal playing method | Shenzhen Xinyang Chuangzhi Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | INBIOSE N V (BE) | 2026-05-21 | — | — | US | disclosed |
| CN-119662773-B | Reagent and method for screening 3-sialyltransferase mutant by high-throughput plate | 深圳瑞德林生物技术有限公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-3952882-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF PAIN | Intrinsic Medicine, Inc. (US) | 2022-02-16 | — | — | EP | disclosed |
| CN-114038095-A | Emergency code unlocking method and system | 南京东屋电气有限公司 | 2022-02-11 | — | — | CN | disclosed |
| US-20220030493-A1 | METHOD AND APPARATUS FOR RESELECTING RELAY BASED ON SL RLF | LG ELECTRONICS INC. (KR) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | GALNT3, NANS, ENGASE | SIGLEC7 512/4885MAG 1618/4885SELP 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.